Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept

There is a relative lack of evidence about systemic treatments in patients with hepatocellular carcinoma (HCC) and moderate liver dysfunction (Child-Pugh B). In this multicenter study we retrospectively analyzed data from Child-Pugh B-HCC patients naïve to systemic therapies, treated with MC or best...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lorenzo, Stefania, Tovoli, Francesco, Barbera, Maria Aurelia, Garuti, Francesca, Palloni, Andrea, Frega, Giorgio, Garajovà, Ingrid, Rizzo, Alessandro, Trevisani, Franco, Brandi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030080/
https://www.ncbi.nlm.nih.gov/pubmed/29968763
http://dx.doi.org/10.1038/s41598-018-28337-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030080/
https://www.ncbi.nlm.nih.gov/pubmed/29968763
http://dx.doi.org/10.1038/s41598-018-28337-6

Ejemplares similares